LIND RESEARCH
Research Note | Premium Equity Research
Lands Two Swiss Deals in 17 Days
PTRK announced its second Swiss institutional deal in under three weeks, with bespoke clinical workflow modules that materially raise switching costs. The deals themselves are small, but the pattern of enterprise traction is building. The stock trades at SEK 8.8 versus our SEK 22-25 SOTP, held down by mid-transition optics, indiscriminate SaaS repricing, and Nordic small-cap outflows. The bigger catalyst remains a US win...
Become a Premium member to read the rest.
Get full access to deep-dive equity research, discovery reports, and premium insights — free for 7 days, just start reading.
Upgrade